Intrinsic Value of S&P & Nasdaq Contact Us

Sharecare, Inc. SHCR NASDAQ

NASDAQ Global Select • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
44/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$3.14
+119.6%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Sharecare, Inc. (SHCR) .

Criteria proven by this page:

  • VALUE (100/100, Pass) — analyst target implies upside (+119.6%).
  • Analyst consensus target $3.14 (+119.6% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 44/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
44/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
~
FUTURE
52/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
MOAT
28/100
→ Income
~
GROWTH
48/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — SHCR

Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio1.13
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.36
Book Value / Share$0.00
Revenue / Share$1.26
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Analyst Target$3.14 (+119.6%)

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2018 $-29.53 $341.87M $-55.93M -16.4%
2019 $-0.12 $339.54M $-39.44M -11.6%
2020 $-0.26 $328.81M $-56.56M -17.2%
2021 $-0.30 $412.82M $-85.13M -20.6%
2022 $-0.34 $442.42M $-119.49M -27%
2023 $-0.36 $445.25M $-128.5M -28.9%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message